COVID-19 and diabetes: Analysis of the scientific production indexed in Scopus #MMPMID33831772
Corrales-Reyes IE; Hernandez-Garcia F; Mejia CR
Diabetes Metab Syndr 2021[May]; 15 (3): 765-770 PMID33831772show ga
BACKGROUND AND AIM: COVID-19 has affected the world population, with a higher impact among at-risk groups, such as diabetic patients. This has led to an exponential increase in the number of studies related to the subject, although their bibliometric characteristics are unknown. This article aims to characterize the world scientific production on COVID-19 and diabetes indexed in Scopus. METHODS: Articles on the subject were retrieved using a search strategy and bibliometric indicators of production, visibility, collaboration and impact were studied. RESULTS: The total scientific production was 1956 documents, which have 35086 citations and an h-index of 67. Articles published in Diabetes and Metabolic Syndrome: Clinical Research and Reviews (n = 127), as well as those by researchers from the United States (n = 498) predominated. Articles by Chinese authors (n = 314) had the highest impact according to the received citations (n = 21757). India, China and Spain are leading countries in terms of the research in which they participate. There is extensive international scientific collaboration led by China, the United States and Italy. CONCLUSION: The volume of publications on COVID-19 and diabetes and their scientific impact show the incentive that the study of these diseases represents for the scientific community worldwide.
Diabetes+Metab+Syndr 2021 ; 15 (3): 765-770
